ISSN:
1432-0428
Keywords:
Acetazolamide
;
albuminuria
;
diabetic nephropathy
;
glomerular filtration rate
;
lithium clearance
;
normal subjects
;
proximal tubules
;
sodium excretion
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary We investigated the effects of 3 days treatment with acetazolamide 250 mg three times daily on kidney function in 8 Type 1 (insulin-dependent) diabetic patients with nephropathy, and in 7 healthy subjects in a double-blind placebo controlled cross-over study. Glomerular filtration rate and extracellular fluid volume were measured with the single injection 51Cr-EDTA technique and fluid flow rate from the proximal tubules was determined by measurement of the renal lithium clearance. A 24% decline in glomerular filtration rate was observed in both groups during acetazolamide treatment (control subjects: 108±11 vs 82±9 ml/min, p〈0.02, diabetic patients: 71±19 vs 54±14 ml/min, p〈0.01). The renal lithium clearance (ml/min) remained about the same (control subjects: 22±6 vs 27±8, NS, diabetic patients: 14±5 vs 15±4, NS). Absolute proximal tubular reabsorption of water (ml/min) was reduced by about one-third (control subjects: 85±11 vs 56±7, p〈0.02, diabetic patients: 55±17 vs 37±6, p〈0.02), and fractional proximal reabsorption of water and sodium (%) declined (control subjects: 79±5 vs 67±8, p〈0.02, diabetic patients: 79±5 vs 72±6, p〈0.02). Renal sodium clearance and distal fractional reabsorption of sodium was unchanged. Extracellular fluid volume declined by 10% in both groups (p〈0.02). Albuminuria and fractional albumin clearance decreased significantly in the nephropathic patients (p〈0.02). Our study suggests that the effects of acetazolamide on kidney function are similar in healthy subjects and patients with diabetic nephropathy.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00277481
Permalink